In an asthmatic patient experiencing acute bronchospasm after exposure to pollen, which mechanism explains why administering a beta-agonist inhaler might not fully resolve the respiratory distress?

💡 Explanation

Beta-agonists primarily relax bronchial smooth muscle; however, because mast cells release histamine, leukotrienes, and other inflammatory mediators during an allergic reaction, beta-agonists alone may not fully counteract all bronchoconstrictive effects. Therefore, addressing histamine's effects is necessary, rather than relying solely on beta-agonists.

• Why does excessive joint loading during weightlifting increase the risk of osteoarthritis in the knee, rather than tendinitis?
• Why does prolonged muscle immobilization lead to decreased force generation during subsequent contractions?
• If a patient with rheumatoid arthritis develops a genetic mutation causing constitutive activation of NF-κB in synovial fibroblasts, which consequence follows regarding the inflammatory prostaglandin pathway?
• If a drug selectively blocks the reuptake transporter for dopamine at the synapse, which consequence follows?
• A patient with cystic fibrosis experiences severely impaired nutrient absorption despite supplemental digestive enzymes. Which process is responsible for this outcome?
• If a patient with diabetes experiences impaired microcirculation in a lower limb and develops a chronic, non-healing ulcer, which mechanism MOST likely prevents effective wound closure?